A common objective in comparative two-treatment randomized clinical trials is the study of the possible heterogeneity of the treatment effect across subgroups of patients, with the objective of identifying patients who benefit the most (or the least) from a new treatment. Here we describe the connection that exists between an exploratory approach to such problem (STEPP, or the Subpopulation Treatment Effect Pattern Plot approach) and the Lorenz curve, and in particular the generalized Lorenz curve. We exploit such connection to construct a test for the absence of interaction between a continuous covariate and the difference in the mean of a continuous outcome between the two treatment groups. We also review some recent developments in the study of concentration for right censored survival data, which are also closed related to the Lorenz curve.
Introduction
Consider the general setting of comparing a new treatment against standard therapy in a two-arm randomized clinical trial. It is often of interest to study the heterogeneity of the treatment effect across groups of patients, to try and identify subgroups of patients who may benefit the most (or the least) from the new therapy, so that treatment can be tailored to the individual patient. Here we focus on the case in which subgroups are defined with respect to a onedimensional covariate X -say, a biomarker or a baseline risk index.
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The presence of an interaction effect is defined as the situation in which the effect of the new treatment on the outcome measure Y as compared to the standard treatment varies as X varies. One may test for the presence of an interaction effect within a regression model. For example, one could use a fractional polynomial (FP) model both overall and within each treatment group (see Royston and Sauerbrei, 2008) . In that case, the first step is to construct a multivariable adjustment model which may contain binary covariates and fractional polynomial transformations of any continuous covariates. The second step involves the fractional polynomial modelling within the adjustment model. This approach is more flexible than the standard polynomial regression and it is useful when one wishes to preserve the continuous nature of the covariate in the regression model, but suspects that some or all of the relationships may be non linear. Potential shortcomings of the fractional polynomial approach are its limited power to detect nonlinear interactions, and the possible sensitivity to extreme values at either end of the distribution of X. Owing to insufficient sample size, variables with a modest or weak effect may not be selected or by default, linear effects may be chosen instead of more realistic non linear functions. In clinical applications, on the other hand, the patient population is often categorized into two or more disjoint groups according to the value of X based on cut-points placed over its support, and the interaction is studied within a model that includes main effects as well as treatment-covariate interaction terms (Altman et al., 1994). Such approach suffers from its dependence on the choice of the cut-points and from the loss of power due to categorization. An alternative approach to the investigation of interactions, that sits between these two extremes, was first introduced in Bonetti and Gelber (2000) within the survival analysis setting, and it is called the Subpopulation Treatment Effect Pattern Plot (STEPP) approach. The approach is reviewed in Section 2. It is based on dividing the observations into subpopulations defined with respect to a collection of cutoff values of the covariate X, and on estimating the treatment effect within each subpopulation. To increase the number of patients that contribute to each point estimate (and hence the precision of the individual estimates) subpopulations are allowed to overlap. Plots showing the estimated treatment effects in the subpopulations can be used to investigate the possible interaction between X and treatment. STEPP is essentially a smoothing-bybinning approach, and it is appealing because it clearly defines the groups of patients on which customary treatment effect measures are calculated using standard methods. Different implementations of STEPP exist that depend on the nature of the outcome of interest. For example, in survival data clinical trials interest may be in the estimated difference between the survival probabilities at some fixed time point t ⇤ between the two treatment groups, across the subpopulations. Other possibilities include the Cox proportional hazards model, or the cumulative incidence function within the competing risks setting (Bonetti and Gelber, 2004; Lazar et al., 2010 ). Here we note the connections that exist between the STEPP construction and ideas related to the Lorenz curve, and in particular to its generalized version based on the regression function. Indeed, the Lorenz curve has been introduced to measure the level of inequality in a population, typically with respect to income or wealth. In Section 3 we recall this concept, and the notion of generalized Lorenz curve (Lorenz, 1905; Kakwani, 1977) . In particular, we focus on the generalized Lorenz curve of the regression function as a tool to measure the dependence between two variables X (real) and Y (positive). By comparing two generalized Lorenz curves of the regression function E(Y |X = x) between two groups in a population, one can study the presence of an interaction, i.e. whether the presence of a differential effect of the continuous predictor X on the outcome variable Y varies between the two groups. We relate this concept to the STEPP construction, show some results, and use them to construct a test for treatment-covariate interactions. In addition, we highlight other recent developments in subgroup identification in clinical studies based directly on concentration ideas, also closely related to the Lorenz curve. We close with some discussion in Section 4.
The Subpopulation Treatment Effect Pattern Plot (STEPP)
STEPP extends the idea of looking at treatment effect within subgroups of patients. In particular, the approach studies patterns of treatment effect across overlapping subpopulations of patients. Consider n patients in a two-arm (randomized) clinical trial, with a continuous baseline covariate X 2 [x min , x max ] ⇢ < 1 observed on all patients, and define K overlapping subpopulations of patients with respect to their values of X. Subpopulations (P j , j = 1, ..., K) can be constructed according to a sliding window pattern: assign a patient i to subpopulation P j when x i 2 [l j , u j ], where the two nondecreasing sets of numbers IASSL ISSN -1391-4987
p)} for some fixed p 2 (0, 1), with P n the empirical distribution of X in the data. Subpopulations in the sliding window construction have an overlapping part and a part that differs from the neighboring supopulations.The patient with index i having covariate value x i belongs to subpopulation P j if l j  x i  u j .
As another possibility, the tail oriented construction produces subpopulations by removing patients from the whole patient population, starting with the ones with the highest (or lowest) values of X. With increasing distance from the center, more and more patients with high covariate values (or low covariate values) are dropped. The cutoffs are defined as
Note that, unlike the sliding window approach, the tail oriented construction includes among the subpopulations also the subpopulation that coincides with the set of all patients in the study. 
estimator of survival at time t within treatment group G inside subpopulation Another implementation of STEPP is based on the hazards ratio obtained from fitting a Cox PH model (Bonetti and Gelber, 2000) . This implementation presents some difficulties in its interpretation due to the fact that the same patient typically belongs to more than one subpopulation, and that it is therefore not clear what probability model its survival time follows. Nevertheless, the desire to capture the difference in two survival distributions beyond the probability of surviving beyond up to a specific time point makes this hazards ratio implementation useful.
Other implementations include the case in which treatment effect is defined to be the difference in a quantile of the survival function (say, the median survival time) as described in Bonetti et al. (2009b) . The survival medians in treatment group G (2 {1, 2}) within the K subpopulations are obtained by inversion of
, the vector of the Kaplan-Meier estimators of the sur-
Lastly, treatment effect can be defined within the context of competing risks as the difference in the estimated cumulative incidence function (of, say, the cause of death of interest c) at some fixed time point t ⇤ within each subpopulation: 
can be used, where b ✓ ALL is the measure of treatment effect computed on all patients in the study. The distribution of T can be estimated by sampling repeatedly from the estimated asymptotic distribution of ( b
, and a p-value can thus be produced. Lastly, a simultaneous confidence band around the plot of the estimated treatment effects can be obtained by solving numerically for the equation
for a sample of random variables generated from the estimated asymptotic distribution of the estimates. The parameter represents the widening of the 132 marginal confidence intervals that is necessary to produce the desired simultaneous coverage of the band. Note that Bonferroni adjustment can also be used, as well as marginal confidence intervals for each subpopulation. Alternatively to large sample theory, in general one can also perform more accurate testing by using permutation-based inference (Bonetti et al., 2009b) . Several examples of clinical applications of the various implementations of STEPP can be found in Lazar et al. (2010) . The R stepp package for both the asymptotic and the permutation-based procedures is available on CRAN.
3. Lorenz-Curve, Generalized Lorenz Curve of the Regression Function, and Concentration
The Lorenz Curve
The Lorenz curve (LC) has been used since 1905 to describe concentration and inequality in distributions of resources. Its main importance is in economics, when dealing with income and wealth: it is still considered as a simple method for visualizing distributions of income or wealth with respect to their inherent inequality or concentration, through the graph of the cumulative proportion of total income or wealth owned, against the cumulative proportion of the population owning it. For a nonnegative random variable Y ⇠ f (y) with finite and strictly positive expected value µ = E(Y ), the Lorenz curve is defined as the function (F, C)(y) given by Lorenz, 1905) . Note that this can also be written as
where the quantile function F 1 Y is defined as the pseudoinverse of the cumulative distribution function (cdf), F Y ,
as in Pietra (1915) . (1) = 1. The empirical counterparts of these curves can be expressed in terms of order statistics. In particular, considering n points, let y (i)n denote the i-th smallest value of the random variable Y , with i = 1, ..., n. Then the empirical Lorenz curve is defined as:
with k = 1, . . . , n and with L(0) = 0. (The empirical dual Lorenz curve is defined similarly). Essentially, the Lorenz curve describes the amount of total wealth (say) owned by the p ⇥ 100% poorest individuals, for p 2 [0, 1] (see also Gastwirth, 1971 ).
The Generalized Lorenz Curve of the Regression Function
A generalization of the Lorenz curve has been proposed in Kakwani (1977) . Let g(x) be a continuos function of x such that its first derivative exists, and 
also with p 2 [0, 1] and x p = F 1 X (p) (Blitz and Brittain, 1964) . As a consequence, bivariate distributions can be ordered according to monotone dependence. The symbol= is used below to denote the equivalence of random variables Z 1 and Z 2 : Z 1= Z 2 iff the probability of the event {Z 1 = Z 2 } is equal to one. In particular, the following properties hold:
1. L E(Y |X) (p) passes through the points (0, 0) and (1, 1).
L E(Y |X) (p) is increasing if and only if g(x)
> 0 for all x.
L E(Y |X) (p) is concave if and only if g(x)
is nondecreasing for all x.
L E(Y |X) (p) = p for all p 2 (0, 1) if and only if E(Y |X)=E(Y ).

L E(Y |X) (p) = L Y (p) for all p 2 (0, 1) if and only if g(x)
is increasing and such that E(Y |X)=Y .
L E(Y
|X) (p) = L ⇤ Y (p) for all p 2 (0, 1
) if and only if g(x)
is decreasing and such that E(Y |X)=Y .
If g(x) is nondecreasing for all x then L E(Y |X) (p)  p. The inequalities are reversed if g(x) is nonincreasing. In both cases, cov(X, Y )=0 and L E(Y |X) (p) = p hold if and only if E(Y |X)=E(Y ).
L E(Y
is the class of bivariate nonnegative random variables (X, Y ) with continuous marginal distribution functions F X and F Y . Then L E(Y |X) will be above (below) L E(Y 0 |X 0 ) if the elasticity of E(Y |X = x) is less (greater) than the elasticity of
For the proofs of these properties we refer to Muliere and Petrone (1992 
the dual Lorenz curve as
and the generalized Lorenz curve of the regression function E(
. These functions are represented in Figure 3 .1 (left panel). As noted above, the population GLC curve is contained between the LC and the DLC. By assuming the absolute continuity of (X, Y ), one can prove the following equivalent expression of the generalized Lorenz curve of the regression function:
(see, e.g., Muliere and Petrone, 1992) . Now, let us consider the observed sample (x, y) = ((x 1 , y 1 ) , ..., (x n , y n )) extracted by a bivariate population described by the absolutely continuous random vector (X, Y ). The empirical version of the generalized Lorenz curve can be obtained by using an estimator b g(x) of the regression function g(x) = E(Y |X = x). Or, one may choose to use b g(x) = y(x) for the observed values (x i , y i ), thus constructing the empirical GLC from (3.6) as
An example of empirical LC and GLC is shown in the right panel of Figure 3 .1. The figure shows the Lorenz curve and the dual Lorenz curve corresponding to the sample {X = {3, 7, 2}, Y = {1, 4, 5}}, as well as the estimated generalized Lorenz curve of E(Y |X = x).
Asymptotic Behavior of the Empirical GLC of the Regression Function, and a Test for Interaction
The following result describes the asymptotic behavior of the (scaled) empirical GLC of the regression function as constructed in (3.7) above. 
where b F (x, y) is the ecdf of (X, Y ) and b F 1 X is the empirical quantile function
where G F (u,v) is a zero mean Gaussian process with known covariance function.
We refer to Appendix A for a sketch of the proof of Theorem 3.1. While this result describes the large sample behavior of b
, the fact that its expression involves an integration with respect to a process makes it hard to use in practice. Indeed, we recommend the use of permutation-based inference instead. Note that above we have defined the empirical generalized Lorenz curve of the regression function as:
The GLC of the regression function is therefore related to an increasing sequence of subpopulations defined by the values x p = F 1 X (p) of the predictor X, across all values of p 2 [0, 1]. In particular, for a fixed value p the GLC of the regression function is the ratio between the conditional expected value of Y given that X  F 1 X (p) and the overall expected value of Y . This clearly resembles the tail oriented version of STEPP described in Section 2 when one defines as treatment effect the (estimated) differences in conditional means of exactly the form E(Y |X  F 1 X (p)). For the subpopulations containing all patients that have values of X smaller than the empirical percentiles x p , these are therefore estimated nonparametrically. This parallel suggests alternative tests for interaction, motivated by the comparison of the level of dependence between X and the outcome Y in the two treatment groups, when such dependence is expressed by the GLC of the regression function. In particular, one may study the presence of an interaction effect through the difference between the estimated GLC of the regression function for the two treatment groups
E(Y |X) (p) dp and
⌘ 2 dp.
Inference for the proposed test statistics could be based on Theorem 3.1. However, as noted above, it is more practical to make use of permutation testing. Permutation tests are conditional statistical procedures, where the conditioning is with respect to the permutation set of the observed data which plays the role of reference set for the inference. Under the null hypothesis and assuming exchangeability, the conditional probability distribution of a generic element that belongs to the set of the permutations of the observed data is independent of the distribution P of the data. This allows permutation inference to be invariant with respect to P within H 0 . Due to this invariance property, permutation tests are therefore distribution free and non parametric. To perform a permutation test one follows the customary four steps: (i) define the null hypothesis, the alternative hypothesis, and the assumptions; (ii) choose the appropriate test statistic and calculate its value using the observed data; (iii) calculate the value of the test statistic for all permutations of the data; and (iv) reject or not reject the null hypothesis using the estimated distribution of the test statistic under permutation. When the number of all permutations is very large one typically uses the conditional Monte Carlo approach that chooses a sample of permutations, thus producing an estimate of the exact p-value (Good, 1994) . In our problem one may develop a permutation test under the null hypothesis that F X,Y is equal in the two treatment-defined populations by permuting the pairs of values (X i Y i ) across the two patient groups.
Concentration
An alternative way of studying the differential effect of a new treatment on a subgroup of patients exists that is based directly on the Lorenz curve con- (Gini, 1912) . Asymptotic normality of the empirical Gini index is well known (Hoeffding, 1948) . Importantly, the Gini index G is equal to twice the concentration area, or the area between the 45 degree line and the Lorenz curve. Thus G is consistent with orderings of distributions that are induced by the Lorenz curves. It is therefore reasonable to compare distribution with respect to their concentration. In particular, testing for the equality of two population Gini indices may capture differences in the two distributions that may not be revealed by other measures. Rejection of the null hypothesis of equality of the two outcome distributions of the two patient groups from the point of view of their concentration may suggest that subgroups of patients exist for whom treatment has a strong positive (or detrimental) effect. Equivalently, differences in concentration between groups may suggest the presence of a differential treatment effect on some patient groups. Following these ideas, the use of the Gini index has recently been extended to right-censored survival data arising from clinical studies to detect differences in concentration between the survival time distributions of two treatment groups of patients (Bonetti et al., 2009a ). An alternative expression for G is
One may consider the following restricted version of G:
and estimate it by replacing S Y by its Kaplan-Meier estimator b S Y . Under some regularity conditions, the restricted Gini statistic has an asymptotic normal asymptotic distribution, and a plug-in estimator of its asymptotic variance is available (Bonetti et al., 2009a) . A test is then constructed that compares the estimated (restricted) Gini concentration coefficient between the two treatment groups. The Gini test complements other tests in the sense that it captures differences in survival distributions not typically detected by other tests (e.g. Wilcoxon, Log-rank, or Gray-Tsiatis), and a large simulation study suggests that the Gini index should be considered together with other existing tests to detect differences in survival distributions. Here, too, permutation distribution inference is recommended, but only for the case of small and unbalanced groups (Gigliarano and Bonetti, 2013) . Additional results in that reference apply specifically to cure rate models. An R function for the implementation of the restricted Gini test for right censored survival data is available from the Authors.
Conclusions
As we have seen above, STEPP is an exploratory tool which is easy to interpret, and it provides an opportunity to detect interactions beyond those that may be apparent based on regression models. STEPP may suggest the presence of a pattern in treatment effects, and it falls somewhere between the simple subgroup analyses performed on disjoint patient subgroups and full modeling. When implementing the methods, it is important to assess the robustness of the results of the analysis to the choice of the parameters that define the subpopulations.
As we have discussed here, interesting connections exist between STEPP and Lorenz curves. In particular, starting from the definition of the generalized Lorenz curve of the regression function, we have suggested another way to explore the presence of the interaction effect between treatment and a continuous predictor X. Using test statistics based on the difference of two generalized Lorenz curve of the regression function, one may construct increasing overlapping subpopulations of patients (as in the tail-oriented version of STEPP) and The class of lower rectangles is P -Donsker for any law of (X 1 , Y 1 ), ..., (X n , Y n ), and the indicator function is square integrable (van der Vaart and Wellner, 1996; Das Gupta, 2008). By the central limit theorem for empirical measures, the sequence p n( b F (x, y) F (x, y)), converges weakly to is a zero-mean Gaussian process G F (x,y) with covariance function given by Cov(G F (x i ,y i ) , G F (x j ,y j ) ) = F ((x i^xj ), (y i^yj )) F (x i , y i )F (x j , y j ), where^denotes the minimum and i, j = 1, .., n (van der Vaart and Wellner, 1996) . Lastly, by the functional delta method, one concludes that p n( ( b F (x, y), p) F ((x, y), p) is asymptotically equivalent to R y 1(x  x p )d (G F (x,y) ).
